magnesium carbonate (magnesite)

RN given refers to parent cpd (1:1)

Also Known As:

magnesite; C.I. 77713; CI 77713; E-504; MgCO3.3H2O; anhydrous magnesium carbonate; carbonic acid, magnesium salt (1:1), hydrate; magnesite (Mg(CO3)); magnesium carbonate (1:1) hydrate; magnesium carbonate anhydrous; nesquehonite

Networked: 31 relevant articles (3 outcomes, 5 trials/studies)

Relationship Network

Drug Context: Research Results

Inorganic Chemicals: 9
- Metals: 20694
  - Light Metals
    - Magnesium: 12037
      - magnesium carbonate: 31
- Elements: 18681
  - Alkaline Earth Metals: 20
    - Magnesium: 12037
      - magnesium carbonate: 31
  - Light Metals
    - Magnesium: 12037
      - magnesium carbonate: 31

Experts

1.	Bowden, Mark E: 2 articles (01/2018 - 04/2015)
2.	Kaszuba, John P: 2 articles (01/2018 - 04/2015)
3.	McGrail, Bernard P: 2 articles (01/2018 - 04/2015)
4.	Miller, Quin R S: 2 articles (01/2018 - 04/2015)
5.	Schaef, Herbert T: 2 articles (01/2018 - 04/2015)
6.	Behets, Geert J: 2 articles (01/2014 - 06/2013)
7.	D'Haese, Patrick C: 2 articles (01/2014 - 06/2013)
8.	De Schutter, Tineke M: 2 articles (01/2014 - 06/2013)
9.	Gundlach, Kristina: 2 articles (01/2014 - 06/2013)
10.	Neven, Ellen: 2 articles (01/2014 - 06/2013)

Related Diseases

1.	Vascular Calcification 07/01/2007 - "While short-term or adjuvant use of magnesium carbonate appears safe and effective as a phosphate binder, more studies are needed to evaluate the long-term effects on vascular calcification, bone histology, and mortality." 02/09/2020 - "In the present study, we tested the effect of a new nutraceutical combination named RenaTris®, containing MK-7, magnesium carbonate, and Sucrosomial® Iron, on vascular calcification in uremic rats. " 01/01/2014 - "The alternative phosphate binder calcium acetate/magnesium carbonate (CaMg) effectively reduces hyperphosphatemia, the most important inducer of vascular calcification, in chronic renal failure (CRF). "
2.	Calculi (Calculus) 06/01/2000 - "Urethral catheterization relieved the second obstruction, which was caused by a large calculus composed of calcium carbonate and magnesium carbonate. " 08/01/2007 - "The calculi collected had various shapes and composed of calcium apatite (42.45%), struvite (20.15%), magnesium carbonate (15.15%), calcium carbonate (12.12%), and calcium phosphate cystine (10.13%). "
3.	Peptic Ulcer (Peptic Ulcers) 01/01/1987 - "Sucralfate, one of the newer drugs shown to be effective in the treatment of peptic ulcer and esophagitis; cholestyramine, a known bile acid binder; and commercial antacid preparations of pure aluminum hydroxide, pure magnesium hydroxide, and a combination of aluminum hydroxide, magnesium hydroxide, and magnesium carbonate were tested in vitro for bile acid-binding capacity. "
4.	Esophagitis 01/01/1987 - "Sucralfate, one of the newer drugs shown to be effective in the treatment of peptic ulcer and esophagitis; cholestyramine, a known bile acid binder; and commercial antacid preparations of pure aluminum hydroxide, pure magnesium hydroxide, and a combination of aluminum hydroxide, magnesium hydroxide, and magnesium carbonate were tested in vitro for bile acid-binding capacity. "
5.	Hyperphosphatemia 01/01/2011 - "The aim of the study was to assess short-time magnesium carbonate treatment efficacy in hemodialysis patients with hyperphosphatemia. " 11/01/2016 - "Efficacy and safety of calcium acetate-magnesium carbonate in the treatment of hyperphosphatemia in dialysis patients." 01/01/1996 - "While it was possible to control the patient's hyperphosphatemia using magnesium carbonate, local ulcer care, including daily whirlpool and repeated local surgical excision, failed to stop the progression of the surrounding skin and subcutaneous tissue necrosis with subsequent ulceration. " 01/01/2023 - "Magnesium carbonate has the best phosphorus-lowering effect in hyperphosphatemia adults with CKD; considering efficacy and acceptability, ferric citrate shows evidence to be the most appropriate drug with or without dialysis." 01/01/2014 - "The alternative phosphate binder calcium acetate/magnesium carbonate (CaMg) effectively reduces hyperphosphatemia, the most important inducer of vascular calcification, in chronic renal failure (CRF). "

Related Drugs and Biologics

1.	Phosphates (Orthophosphate)
2.	Calcium Carbonate (Limestone)
3.	Sucralfate (Carafate)
4.	Magnesium Hydroxide (Brucite)
5.	Cholestyramine Resin (Questran)
6.	Bile Acids and Salts (Bile Acids)
7.	Antacids
8.	Aluminum Hydroxide (Algeldrate)
9.	drug combination magnesium hydroxide aluminum hydroxide (Maalox)
10.	Powders

Related Therapies and Procedures

1.	Renal Dialysis (Hemodialysis)
2.	Continuous Ambulatory Peritoneal Dialysis (CAPD)